(Press-News.org) ROCHESTER, Minn. -- Blood offers promise as a way to detect Alzheimer's disease at its earliest onset, Mayo Clinic researchers say. They envision a test that would detect distinct metabolic signatures in blood plasma that are synonymous with the disease -- years before patients begin showing cognitive decline. Their study was recently published online in the journal PLOS ONE.
Researchers analyzed cerebrospinal fluid and plasma samples from 45 people in the Mayo Clinic Study on Aging and Mayo Clinic Alzheimer's Disease Center (15 with no cognitive decline, 15 with mild cognitive impairment and 15 with Alzheimer's disease). They detected significant changes in the cerebrospinal fluid and plasma in those with cognitive decline and Alzheimer's. Most important, changes in plasma accurately reflected changes in the cerebrospinal fluid, validating blood as a reliable source for the biomarker development.
The team uses a relatively new technique called metabolomics, which measures the chemical fingerprints of metabolic pathways in the cell -- sugars, lipids, nucleotides, amino acids and fatty acids -- to detect the changes. Metabolomics assesses what is happening in the body at a given time and at a fine level of detail, giving scientists insight into the cellular processes that underlie a disease. In this case, the metabolomic profiles showed changes in metabolites related to mitochondrial function and energy metabolism, further confirming that altered mitochondrial energetics is at the root of the disease process.
The researchers hope that identified changes in the metabolic pathways could lead to the panel of biomarkers, which can eventually be used on a larger scale for early diagnosis, monitoring of Alzheimer's progression, and evaluating therapeutic approaches, says co-author Eugenia Trushina, Ph.D., a Mayo Clinic pharmacologist.
"We want to use these biomarkers to diagnose the Alzheimer's disease before symptoms appear -- which can be decades before people start exhibiting memory loss," Dr. Trushina says. "The earlier we can detect the disease, the better treatment options we will be able to offer."
###
The study was funded by grants from the National Institute of Environmental Health Sciences to Dr. Trushina, grant number R01ES020715; the National Institute on Aging to the Mayo Clinic Study of Aging, grant number AG006786; and the National Institute on Aging award to the Mayo Clinic Alzheimer's Disease Research Center, grant number AG016574.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.com and http://www.mayoclinic.org/news.
Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.
MULTIMEDIA ALERT: For audio and video of Dr. Trushina talking about the research, visit the Mayo Clinic News Network.
New Mayo Clinic approach could lead to blood test to diagnose Alzheimer's in earliest stage
2013-05-29
ELSE PRESS RELEASES FROM THIS DATE:
Study shows longer treatment for children with langerhans cell hystiocytosis improves survival rates
2013-05-29
Washington, DC—A new international study finds that prolonged, intense initial treatment in children with multi-system Langerhans cell histiocytosis (MS-LCH) can achieve survival rates as high as 84 percent—a full 15 percent improvement over the previous clinical trial in this series.
The study, LCH-III, is published in Blood, the journal of the American Society of Hematology. It is the third in a series of international randomized clinical trials for LCH that spans twenty years initiated and coordinated by the Histiocyte Society, a group of more than 200 physicians and ...
Twitter may become less interactive and more an advertising broadcast medium like TV or radio
2013-05-29
PITTSBURGH—Popular social media site Twitter may eventually resemble a broadcast medium like television or radio, with users reading messages written by celebrities and corporations rather than writing their own "tweet" messages of up to 140 characters, suggests a new study coauthored by Andrew T. Stephen, assistant professor of business administration and Katz Fellow in Marketing in the University of Pittsburgh's Joseph M. Katz Graduate School of Business and College of Business Administration.
In one of the first studies to use social media as a laboratory for social ...
People can 'beat' guilt detection tests by suppressing incriminating memories
2013-05-29
New research published by an international team of psychologists has shown that people can suppress incriminating memories and thereby avoid detection in brain activity guilt detection tests.
Such tests, which are commercially available in the USA and are used by law enforcement agencies in several countries, including Japan and India, are based on the logic that criminals will have specific memories of their crime stored in their brain. Once presented with reminders of their crime in a guilt detection test, it is assumed that their brain will automatically and uncontrollably ...
Pigeons peck for computerized treat
2013-05-29
Go to about any public square, and you see pigeons pecking at the ground, always in search of crumbs dropped by a passerby. While the pigeons' scavenging may seem random, new research by psychologists at the University of Iowa suggest the birds are capable of making highly intelligent choices, sometimes with problem-solving skills to match.
The study by Edward Wasserman and colleagues centered on the "string task," a longstanding, standard test of intelligence that involves attaching a treat to one of two strings and seeing if the participant (human or animal) can reel ...
Study finds that radiation oncology research is critically underfunded by NIH
2013-05-29
Radiation oncology research received 197 grants, totaling only 1.6 percent ($85.5 million) of the $5.4 billion in cancer research funding from the National Institutes of Health (NIH) in Fiscal Year (FY) 2013, according to a study available online and in the June 1, 2013, print issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
The study reviewed the more than 50,000 grants funded by the NIH, totaling $30.9 billion. Investigation revealed 952 ...
Brain haemorrhage patients offered better treatment
2013-05-29
An international trial has provided surgeons with a formula which predicts when brain haemorrhage patients need surgery for the best outcome.
Brain haemorrhage affects some 4 million patients a year worldwide and the trial, run from Newcastle University, will help to ensure the best treatment is given at the right time.
David Mendelow, Professor of Neurosurgery at Newcastle University and honorary consultant within the Newcastle Hospitals NHS Foundation Trust, who ran the trials, has devised a formula published today in The Lancet online which will allow surgeons to ...
'Junk DNA' plays active role in cancer progression, researchers find
2013-05-29
Scientists at The University of Nottingham have found that a genetic rogue element produced by sequences until recently considered 'junk DNA' could promote cancer progression.
The researchers, led by Dr Cristina Tufarelli, in the School of Graduate Entry Medicine and Health Sciences, discovered that the presence of this faulty genetic element — known as chimeric transcript LCT13 — is associated with the switching off of a known tumour suppressor gene (known as TFPI-2) whose expression is required to prevent cancer invasion and metastasis.
Their findings, published online ...
Recovery of Hawaiian green sea turtles still short of historic levels, Stanford-led study suggests
2013-05-29
Calls to lift protections for the iconic Hawaiian green sea turtle may be premature, according to a new study led by a Stanford researcher.
Although the number of Hawaiian green sea turtles has increased since 1978 when the species was listed under the U.S. Endangered Species Act, the population may still be only a fraction of historic levels, the research shows.
"It's critical to compare the animal's population level to its historic abundance, not just to recent levels," said study coauthor John N. "Jack" Kittinger, an early career fellow at Stanford's Center for Ocean ...
Gene therapies for regenerative surgery are getting closer, says review in PRS
2013-05-29
Philadelphia, Pa. (May 29, 2013) – Experimental genetic techniques may one day provide plastic and reconstructive surgeons with an invaluable tool—the ability to promote growth of the patient's own tissues for reconstructive surgery. A review of recent progress toward developing effective gene therapies for use in "regenerative surgery" appears in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the END ...
Tobacco companies are not public health stakeholders
2013-05-29
When assessing information presented by the tobacco industry, the US regulator, the Food and Drug Administration (FDA) and regulatory bodies in other countries, should be aware that they are dealing with companies with a long history of intentionally misleading the public. They therefore should actively protect their public-health policies on smoking from the commercial interests of the tobacco industry and not consider the industry as a stakeholder, concludes a study by experts from the US and Germany published in this week's PLOS Medicine.
The researchers, led by Stanton ...